![](/img/cover-not-exists.png)
Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway
Hong, Seung-Woo, Park, Nam-Sook, Noh, Min Hye, Shim, Ju A, Ahn, Byul-Nim, Kim, Yeong Seok, Kim, Daejin, Lee, Hyun-Kyung, Hur, Dae YoungVolume:
106
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2017.02.009
Date:
April, 2017
File:
PDF, 2.83 MB
english, 2017